Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giacomini

Showing results (281-290 of 378) with videos related to

Pageof 38
Sort By:
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|February 27, 2003
SNP analysis and presentation in the Pharmacogenetics of Membrane Transporters ProjectDoug Stryke, Conrad C Huang, Michiko Kawamoto, et al.
AIDS Care|February 3, 2017
Quality of life in an Italian cohort of people living with HIV in the era of combined antiretroviral therapy (Evidence from I.A.N.U.A. study-investigation on antiretroviral therapy)A Venturini, G Cenderello, A Di Biagio, et al.
BMC Bioinformatics|February 26, 2020
GenEpi: gene-based epistasis discovery using machine learningYu-Chuan Chang, June-Tai Wu, Ming-Yi Hong, et al.
Pharmacogenetics and Genomics|September 23, 2010
Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metforminLigong Chen, Bradley Pawlikowski, Avner Schlessinger, et al.
International Journal of STD & AIDS|February 2, 2017
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maravirocC Dentone, G Sterrantino, A Signori, et al.
Pharmacogenetics|July 27, 2002
Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered functionMaya K Leabman, Conrad C Huang, Michiko Kawamoto, et al.
Molecular Pharmacology|May 4, 2018
Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug ToxicityLing Zou, Adrian Stecula, Anshul Gupta, et al.
Pharmacogenetics and Genomics|April 30, 2005
Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2Ryan P Owen, Jennifer H Gray, Travis R Taylor, et al.
Pharmacogenetics and Genomics|December 9, 2014
A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndromeAmber Dahlin, Matthias Wittwer, Melanie de la Cruz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 11, 2005
Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2Ryan P Owen, Leah L Lagpacan, Travis R Taylor, et al.
Pageof 38

Showing results (281-290 of 378) with videos related to

Sort By:
Pageof 38
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing|February 27, 2003
SNP analysis and presentation in the Pharmacogenetics of Membrane Transporters ProjectDoug Stryke, Conrad C Huang, Michiko Kawamoto, et al.
AIDS Care|February 3, 2017
Quality of life in an Italian cohort of people living with HIV in the era of combined antiretroviral therapy (Evidence from I.A.N.U.A. study-investigation on antiretroviral therapy)A Venturini, G Cenderello, A Di Biagio, et al.
BMC Bioinformatics|February 26, 2020
GenEpi: gene-based epistasis discovery using machine learningYu-Chuan Chang, June-Tai Wu, Ming-Yi Hong, et al.
Pharmacogenetics and Genomics|September 23, 2010
Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metforminLigong Chen, Bradley Pawlikowski, Avner Schlessinger, et al.
International Journal of STD & AIDS|February 2, 2017
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maravirocC Dentone, G Sterrantino, A Signori, et al.
Pharmacogenetics|July 27, 2002
Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered functionMaya K Leabman, Conrad C Huang, Michiko Kawamoto, et al.
Molecular Pharmacology|May 4, 2018
Molecular Mechanisms for Species Differences in Organic Anion Transporter 1, OAT1: Implications for Renal Drug ToxicityLing Zou, Adrian Stecula, Anshul Gupta, et al.
Pharmacogenetics and Genomics|April 30, 2005
Genetic analysis and functional characterization of polymorphisms in the human concentrative nucleoside transporter, CNT2Ryan P Owen, Jennifer H Gray, Travis R Taylor, et al.
Pharmacogenetics and Genomics|December 9, 2014
A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndromeAmber Dahlin, Matthias Wittwer, Melanie de la Cruz, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 11, 2005
Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2Ryan P Owen, Leah L Lagpacan, Travis R Taylor, et al.
Pageof 38